GAMHALTY
Dead / Cancelled — Cancelled — Section 8 (as of 17 Jan 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87283837
- Registration number
- 5505934
- Mark type
- Stylized text
- Filed
- 29 Dec 2016
- Published for opposition
- 17 Apr 2018
- Registered
- 03 Jul 2018
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 001 — Chemicals: Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune response, all for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for medical purpose for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemical substance, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies, namely engineered T cells, immune cells, and antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes
Owner
- NovImmune SA, Geneva, CH
- NovImmune SA, Geneva, CH
- NovImmune SA, Geneva, CH
Prosecution history
- 17 Jan 2025 — CANCELLED SEC. 8 (6-YR)
- 03 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Apr 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Apr 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 20 Apr 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 20 Apr 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Apr 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Apr 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 17 Apr 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Apr 2018 — PUBLISHED FOR OPPOSITION
- 28 Mar 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED